A case of malignant peritoneal mesothelioma.
10.3760/cma.j.cn121094-20220328-00158
- Author:
Fang ZHAO
1
;
Ying Liang ZHANG
1
;
Xi LIU
1
;
Ting Hao CHEN
1
;
Jing LI
1
Author Information
1. General Surgery of Ziyang First People's Hospital, Ziyang 641300, China.
- Publication Type:Journal Article
- Keywords:
Malignant tumor;
Mesothelioma;
Peritoneal tumor
- MeSH:
Humans;
Mesothelioma, Malignant/drug therapy*;
Mesothelioma/diagnosis*;
Pemetrexed/therapeutic use*;
Cisplatin/therapeutic use*;
Peritoneal Neoplasms/diagnosis*;
Pleural Neoplasms;
Lung Neoplasms/drug therapy*
- From:
Chinese Journal of Industrial Hygiene and Occupational Diseases
2023;41(4):307-309
- CountryChina
- Language:Chinese
-
Abstract:
Malignant mesothelioma is a highly malignant disease that most often occurs in the pleural cavity, followed by the peritoneum and pericardium. Malignant peritoneal mesothelioma (MPM) accounts for 10%-15% of all mesothelioma. The most important risk factor for MPM is exposure to asbestos. MPM has no specific clinical symptoms, imaging and histopathology are critical for the diagnosis. There are currently no generally accepted guidelines for curative treatment of MPM. The patient mainly presented with abdominal pain, abdominal distension and discomfort. Due to extensive omentum metastasis, no further surgical treatment was performed. Pemetrexed combined with cisplatin chemotherapy was given for 2 cycles, and the patient is still alive.
